Doses used in ARA-290 human trials Study context Sarcoidosis pilot (2012) Dose & route 2 mg IV Schedule 3x/week, 4 weeks Study context Sarcoidosis SFN (2013) Dose & route Daily subQ Schedule 28 days Study context Type 2 diabetes neuropathy (2014) Dose & route 4 mg subQ Schedule Daily, 28 days Study context Phase 2b sarcoidosis (2017) Dose & route 1, 4, or 8 mg subQ Schedule Daily, 28 days Study context Diabetic macular edema (2020) Dose & route 4 mg subQ Schedule Daily, 12 weeks This is trial reporting, not a dosing recommendation
[DOI] [PMC free article] [PubMed] [Google Scholar] 19.Sena L.A., Chandel N.S
The Science Behind GHK-Cu, 100mg Product Name: GHK-Cu Strength: 100mg Chemical Name: Copper Tripeptide Glycyl-L-Histidyl-L-Lysine Complex CAS Number: 89030-95-5 Molecular Formula: CHCuNO Molecular Weight: 401.91 g/mol Amino Acid Sequence: Gly-His-Lys Appearance: Blue-Purple Lyophilized Powder Classification: Peptide-Metal Research Compound Purity: Verified by analytical testing prior to release Analytical Methods: HPLC, Mass Spectrometry (MS)
Dee Dee Goldpaugh: How do we go from, um, I feel better to, I am engaged with the world, right
